Dutch company Luxexcel has announced a collaboration with Vuzix Corp to 3D Print prescription lenses for the Vuzix Blade AR headset.The Luxexcel VisionPlatform enables 3D printing of ophthalmic lenses for specialty applications including Augmented Reality applications. The company recently implemented two VisionPlatform products to locations in the U.S.
Hans Streng, CEO of Luxexcel declared regarding this collaboration: “60% of the US population needs eye correction. Without custom prescription inserts, those people will not be able to fully enjoy the most advanced new augmented reality products. Luxexcel is thrilled to partner with Vuzix as the early adopter of 3D printed ophthalmic lens inserts. We see great synergy between the amazing innovations of Vuzix and the technology of Luxexcel”.
As for Paul Travers, President/CEO of Vuzix, he explained how much they are delighted that with the 3D printed prescription lenses provided by Luxexcel, a much broader audience can enjoy their unique new product, the Vuzix Blade.
3D printed lenses are the next revolution in eye correction since it offers full freedom of lens-design and freedom to embed smart-functions into an ophthalmic lens. This entry into the AR/VR segment is a glimpse into the potential the Luxexcel 3D printing technology brings to smart eyewear and other products.
For further information about 3D Printing, follow us on our social networks and subscribe to our newsletter!
//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
(adsbygoogle = window.adsbygoogle || []).push({});
THE 3D ADEPT WEEKLY NEWSLETTER
The industry moves fast. Stay ahead.
Every week, the latest additive manufacturing news, in-depth features and real-world applications, straight to your inbox. Plus, be the first to know when a new issue of 3D ADEPT Mag is out.
Free · One email a week · Unsubscribe anytime
Clicking loads our email provider’s sign-up form, including its analytics and Google’s anti-bot protection. You’re only subscribed if you complete the sign-up. Read our privacy policy.